文献速递肿瘤 PET/CT放射性药物与辐射防护

SUV可作为复杂结核病病变范围与疗程的潜在预测指标

SUV as a Possible Predictor of Disease Extent and Therapy Duration in Complex Tuberculosis.
PubMed 文献 · Clin Nucl Med · 2018-01-01

回顾性纳入37例治疗前接受F-FDG PET/CT评估的活动性结核患者,分析参考病灶SUVmax与疗程及病变范围的关系。疗程超过9个月者SUVmax显著更高(10.1 vs 5.5,P=0.036);SUVmax=10区分标准与长疗程的灵敏度50%、特异度78.6%(P=0.087)。较高SUVmax与更多器官系统受累及胸外受累相关。

要点

  • 疗程超过9个月者参考病灶SUVmax显著高于标准疗程者(10.1 vs 5.5,P=0.036)。
  • SUVmax=10区分标准与长疗程的灵敏度50%、特异度78.6%,P=0.087。
  • 较高SUVmax与受累器官系统数更多及胸外受累相关,胸外受累者疗程显著更长(P=0.011)。

核心结论

  • 治疗前F-FDG PET/CT参考病灶SUVmax在复杂结核病例中可能具有预后价值,尤其关于疗程和病变范围。

研究设计与样本

  • 回顾性识别37例(男21例、女16例,平均年龄50.4岁)在治疗开始前因活动性结核评估接受F-FDG PET/CT的患者。

主要发现

  • 中位疗程10个月(四分位距3.25个月),中位SUVmax为8(四分位距8.54)。
  • 疗程超过9个月者SUVmax显著更高(10.1 vs 5.5,P=0.036)。
  • SUVmax截断值10区分标准与长疗程组的灵敏度50%、特异度78.6%(P=0.087)。
  • 较高SUVmax对应受累器官系统数更多(≤1 vs >1,P=0.012)。
  • 胸外受累者SUVmax显著高于仅胸腔内病变者(P=0.024),且接受显著更长的抗分枝杆菌治疗(P=0.011)。

关键数值与推荐

  • 标准疗程定义为≤9个月,长疗程定义为>9个月。
  • SUVmax截断值10区分标准与长疗程组:灵敏度50%、特异度78.6%(P=0.087)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: F-FDG PET/CT provides information on disease extension and activity in neoplastic and inflammatory conditions. So far, little is known about whether SUVmax of a reference lesion can allow a prognosis to be given regarding patient-specific outcome parameters in complex cases of tuberculosis (TB). METHODS: We retrospectively identified 37 patients (21 men, 16 women; mean age, 50.4 years) who underwent F-FDG PET/CT for the evaluation of active TB before treatment initiation. The aims were to examine whether the reference lesion SUVmax differed between patients with standard (≤9 months) and long-term (>9 months) therapy and to define an SUVmax cutoff distinguishing those groups. In addition, we analyzed the prognostic value of SUVmax with regard to estimation of initial disease extent and lesion distribution pattern. RESULTS: Median therapy duration was 10 months (interquartile range, 3.25 months), and median SUVmax was 8 (interquartile range, 8.54). SUVmax was significantly (P = 0.036) higher in patients treated longer than 9 months (10.1 vs 5.5). When applying a receiver operating characteristic curve analysis, an SUVmax cutoff value of 10 differentiated the standard and the long-term therapy group with a sensitivity of 50% and a specificity of 78.6% (P = 0.087). Higher SUVmax corresponded with a larger number of affected organ systems (P = 0.012 for ≤/>1). Patients with extrathoracic involvement showed significantly higher SUVmax than did patients with limited intrathoracic disease (P = 0.024) and received significantly longer antimycobacterial therapy (P = 0.011). CONCLUSIONS: Reference lesion SUVmax from pretherapy F-FDG PET/CT may have prognostic properties in complicated cases of TB, especially regarding therapy duration and disease extent.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lang D, Huber H, Kaiser B, et al. SUV as a Possible Predictor of Disease Extent and Therapy Duration in Complex Tuberculosis. Clin Nucl Med. 2018. PMID: 29215403. doi:10.1097/RLU.0000000000001895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。